NewAmsterdam Pharma (NAMS) EPS (Basic) (2023 - 2026)
NewAmsterdam Pharma (NAMS) reported EPS (Basic) of -$0.4 for Q1 2026, down 16.92% on a YoY basis from -$0.48 in Q1 2025, and up 37.09% sequentially from -$0.63 in Q4 2025.
NewAmsterdam Pharma (NAMS) EPS (Basic) (2023 - 2026) Analysis & Trends
NewAmsterdam Pharma (NAMS) has 4 years of EPS (Basic) data on file, last reported at -$0.4 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 16.92% year-over-year to -$0.4; the trailing twelve-month figure through Mar 2026 stood at -$1.75 (down 8.33% YoY), and the FY2025 full-year result was -$1.71, up 33.21% from the prior year.
- EPS (Basic) advanced to -$0.4 in Q1 2026, from -$0.63 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.71 in Q4 2023 to a low of -$1.06 in Q1 2024.
- A 4-year average of -$0.43 and a median of -$0.46 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 69.26% in 2024 and tumbled 244.41% in 2025, its largest moves.
- Tracing NAMS's EPS (Basic) over 4 years: stood at $0.71 in 2023, then tumbled by 238.18% to -$0.98 in 2024, then jumped by 35.24% to -$0.63 in 2025, then surged by 37.09% to -$0.4 in 2026.
- Business Quant data shows NAMS's EPS (Basic) at -$0.4 in Q1 2026, -$0.63 in Q4 2025, and -$0.61 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | NewAmsterdam Pharma | 3.64 Bn | 3.64 Bn | - | -0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.40 |
| Dec 31, 2025 | -0.63 |
| Sep 30, 2025 | -0.61 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.34 |
| Dec 31, 2024 | -0.98 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.41 |
| Mar 31, 2024 | -1.06 |
| Dec 31, 2023 | 0.71 |
| Sep 30, 2023 | -0.57 |
| Mar 31, 2023 | -0.51 |